Vardenafil (Levitra/Staxyn) Cost in Utah 2026: Prices, Insurance, and Savings

At a glance
- Brand Levitra list price / ~$350 per month (Bayer)
- Average Utah generic cash price / ~$120 per month at retail pharmacies
- Utah Medicaid ED coverage / Not covered for vardenafil
- Compounded vardenafil / Legal via licensed 503A pharmacies in Utah
- Telehealth prescribing / Permitted statewide in Utah
- Dosing schedule / On-demand, 30 to 60 minutes before sexual activity
- Available forms / Oral tablet (Levitra) and orally disintegrating tablet (Staxyn)
- FDA approval / 2003 for erectile dysfunction in adult men
What Does Vardenafil Cost in Utah Right Now?
Utah residents filling a vardenafil prescription in 2026 face a wide price range depending on whether they choose brand or generic. Brand-name Levitra from Bayer carries a manufacturer list price of approximately $350 per month, while generic vardenafil averages around $120 per month across Utah retail pharmacies.
That $230 gap matters. Generic vardenafil contains the same active ingredient at the same dose and is rated as therapeutically equivalent by the FDA. Prices fluctuate between pharmacies in Salt Lake City, Provo, Ogden, and St. George, so checking multiple locations or using a pharmacy price comparison tool before filling is worth the effort. Costco and independent pharmacies in the Wasatch Front corridor tend to price generics 10 to 20 percent below chain drugstores, based on 2025 to 2026 cash-pay aggregator data.
Staxyn, the orally disintegrating tablet formulation, is typically priced higher than standard Levitra tablets due to the specialized delivery system. Most Utah pharmacies stock the standard tablet rather than Staxyn, so patients wanting the ODT form may need to request it or check availability in advance.
The original phase III data from Porst et al. (2003) established vardenafil 20 mg as effective in 80% of intercourse attempts versus 30% with placebo, a finding that supported FDA approval and continues to underpin clinical use across all PDE5 inhibitors prescribed today [1].
Does Utah Medicaid Cover Vardenafil?
No. Utah Medicaid does not cover vardenafil (Levitra or Staxyn) for erectile dysfunction as of 2026. This exclusion applies to both brand and generic formulations.
The exclusion is not unique to Utah. Most state Medicaid programs removed erectile dysfunction drugs from their formularies after the Deficit Reduction Act of 2005 prohibited federal Medicaid funding for ED medications. Utah followed this federal guidance and has not reinstated coverage. Patients enrolled in Utah Medicaid who need PDE5 inhibitor therapy for ED must pay entirely out of pocket or explore alternative coverage pathways.
There is one narrow exception worth knowing. If vardenafil is prescribed for pulmonary arterial hypertension (an off-label but clinically documented use for PDE5 inhibitors), Medicaid may cover it under a different therapeutic class. The prescribing physician would need to submit prior authorization with supporting clinical documentation. This pathway is uncommon for vardenafil specifically, since sildenafil (as Revatio) holds the primary PAH indication, but it exists.
For the roughly 400,000 Utah adults enrolled in Medicaid, the out-of-pocket cost at $120 per month for generic vardenafil represents a real access barrier. Patient assistance programs and compounded alternatives (discussed below) become the primary cost-reduction options [2].
Is Compounded Vardenafil Legal in Utah?
Yes. Compounded vardenafil is legal in Utah when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription.
Under FDA guidance on 503A compounding, these pharmacies may compound medications that are commercially available if the prescriber determines a clinical need for a customized formulation, such as a different dose strength, sublingual troche, or combination product. Utah's Division of Occupational and Professional Licensing (DOPL) oversees pharmacy compounding within the state, and 503A pharmacies must comply with both state and federal regulations.
The practical result for patients: compounded vardenafil is often significantly cheaper than commercial tablets. Some Utah-based 503A pharmacies and telehealth-affiliated compounding services offer vardenafil at substantial discounts compared to retail generic pricing. Compounded formulations may come as sublingual troches, oral suspensions, or combination tablets (vardenafil plus other agents) that are not available commercially.
A few caveats apply. Compounded drugs are not FDA-approved products. They do not undergo the same bioequivalence testing as FDA-rated generics. The American Urological Association guidelines on ED treatment reference PDE5 inhibitors broadly but do not specifically endorse compounded formulations over commercial generics. Patients should confirm their compounding pharmacy holds current licensure with the Utah DOPL and meets USP 795 standards for non-sterile compounding [3].
Insurance Coverage for Vardenafil in Utah
Commercial insurance coverage for vardenafil in Utah is inconsistent. Some plans cover it. Many do not. Those that do almost always impose restrictions.
The most common restrictions include prior authorization requirements, step therapy (requiring a trial of sildenafil first), and quantity limits. A typical quantity limit allows 6 to 12 tablets per month. Plans from SelectHealth, the University of Utah Health Plans, and Regence BlueCross BlueShield of Utah each handle PDE5 inhibitor coverage differently, and formulary status can change at each annual renewal.
Here is what to check before assuming your plan covers vardenafil:
Formulary tier. Generic vardenafil, if covered, usually sits on Tier 2 or Tier 3. Brand Levitra almost always falls on Tier 3 or the specialty tier, meaning higher copays ranging from $50 to $150 per fill.
Prior authorization. Many Utah insurers require documentation of ED diagnosis and, in some cases, evidence that the condition relates to a covered medical cause such as diabetes, prostatectomy, or spinal cord injury. A 2020 review in The Journal of Sexual Medicine found that prior authorization requirements for PDE5 inhibitors delayed treatment initiation by an average of 2.3 weeks [4].
Step therapy. Generic sildenafil (Viagra's equivalent) costs less than generic vardenafil, so insurers often mandate a sildenafil trial first. If sildenafil proves ineffective or causes unacceptable side effects (headache, visual disturbance, flushing), the prescriber can request a step therapy override for vardenafil.
Employer-sponsored plans. Large Utah employers including Intermountain Health, the LDS Church, and Zions Bancorporation each contract their own pharmacy benefit designs. Coverage specifics depend on the employer's plan document, not just the insurer name on the card. Call the number on your pharmacy benefit card and ask specifically about "generic vardenafil, NDC-level coverage" to get a clear answer.
What Is the Cheapest Way to Get Vardenafil in Utah?
Several strategies can reduce vardenafil costs well below the $120 per month Utah average.
GoodRx and similar discount cards. Free pharmacy discount programs aggregate negotiated rates from pharmacy benefit managers. In Utah, these cards frequently bring generic vardenafil down to $30 to $80 for a monthly supply of 10 mg or 20 mg tablets, depending on the pharmacy. Discount card prices are not insurance and cannot be combined with insurance copays.
Manufacturer savings programs. Bayer previously offered a Levitra savings card that reduced brand copays for commercially insured patients. As of 2026, the brand savings program availability has diminished since generic entry, but generic manufacturers occasionally run rebate programs through pharmacy partners. Check directly with the dispensing pharmacy for any active generic vardenafil rebates.
Pill splitting. Vardenafil 20 mg tablets can be split to yield two 10 mg doses if 10 mg is the prescribed amount. This effectively halves the per-dose cost. The FDA-approved prescribing information for vardenafil notes that the tablets are film-coated and not scored, so a pill splitter (not a knife) should be used, and Staxyn ODT tablets must never be split [5]. Discuss this approach with your prescriber first.
Compounding pharmacies. As noted above, 503A compounding pharmacies in Utah may offer vardenafil formulations at lower prices than retail generics. Telehealth platforms that partner with compounding pharmacies sometimes bundle the consultation fee and medication cost together.
90-day fills. Filling a 90-day supply instead of three separate 30-day fills typically reduces the per-tablet cost by 10 to 25 percent at both retail and mail-order pharmacies. Utah-based mail-order pharmacies and national services like Express Scripts or Optum Rx offer this option.
How Vardenafil Compares to Other PDE5 Inhibitors on Cost in Utah
Price should not be the only factor when choosing an ED medication, but it is a practical one. Here is how vardenafil stacks up against other PDE5 inhibitors available in Utah.
Generic sildenafil is the cheapest option. Cash prices run $10 to $40 per month for most Utah pharmacies. This price advantage is why insurers use sildenafil as step therapy before approving vardenafil. Sildenafil's half-life is roughly 4 hours, similar to vardenafil's 4 to 5 hours [6].
Generic tadalafil (Cialis) costs $30 to $90 per month in Utah. Tadalafil offers a longer duration of action (up to 36 hours) and a daily low-dose option (2.5 mg or 5 mg) that some men prefer for spontaneity. A head-to-head meta-analysis published in European Urology found no statistically significant difference in overall efficacy between vardenafil and tadalafil, though patient preference varied based on onset speed and duration [7].
Avanafil (Stendra) remains more expensive, typically $50 to $70 per tablet without insurance. It is rarely the first-choice option on cost grounds alone, though its 15-minute onset is faster than vardenafil's 30 to 60 minutes.
Vardenafil occupies a middle position. At $120 per month retail (before discounts), it costs more than sildenafil but offers a different side-effect profile that some patients tolerate better. The Porst et al. trial demonstrated that vardenafil produced statistically significant improvements in the International Index of Erectile Function (IIEF) erectile function domain score, with a mean increase of 9.5 points over placebo for the 20 mg dose [1]. For men who experience visual disturbances with sildenafil or want a shorter duration than tadalafil, vardenafil fills a specific clinical niche.
Telehealth Access to Vardenafil in Utah
Utah permits telehealth prescribing of vardenafil. A physician or advanced practice provider licensed in Utah can evaluate, diagnose, and prescribe ED medication via video or audio visit without requiring an in-person exam first.
Utah's telehealth prescribing laws were clarified during the COVID-19 public health emergency and many of those expanded provisions were made permanent through H.B. 30 (2021) and subsequent legislative updates. The Utah Division of Professional Licensing recognizes telehealth encounters as valid for establishing a prescriber-patient relationship, provided the encounter meets the standard of care.
Several national telehealth platforms serve Utah residents for ED prescriptions. These services typically charge $30 to $99 for the initial consultation and may bundle medication costs. HealthRX offers telehealth evaluation for vardenafil prescriptions to Utah residents, with board-certified physicians reviewing each case before prescribing.
One regulatory note: the Ryan Haight Act requires that at least one medical evaluation occur before prescribing controlled substances via telehealth, but vardenafil is not a controlled substance. It is a prescription-only medication, which means the telehealth prescribing pathway is more straightforward than it would be for Schedule III or IV drugs [8].
Utah-Specific Discount and Assistance Programs
Beyond the national discount card programs, a few Utah-specific resources can help reduce vardenafil costs.
Utah Health Policy Project (UHPP). This nonprofit helps uninsured and underinsured Utah residents connect with coverage options and pharmacy assistance programs. While they do not directly subsidize vardenafil, their navigators can identify whether a patient qualifies for marketplace coverage that includes PDE5 inhibitor benefits.
University of Utah Health Pharmacy. The U of U Health system pharmacies occasionally offer competitive generic pricing for patients within their health network. Patients already receiving care through University of Utah clinics should compare in-network pharmacy pricing against retail alternatives.
Intermountain Health prescription programs. Intermountain's SelectHealth plans and affiliated pharmacies sometimes run preferred generic pricing programs. Patients filling prescriptions at Intermountain-affiliated pharmacies should ask about any active generic preferred pricing.
Needymeds.org and RxAssist. These national databases track patient assistance programs by medication name. Searching for "vardenafil" on either site can surface active programs, including generic manufacturer copay assistance and state-specific charity programs that periodically cover ED medications.
The American Urological Association's 2018 guideline update on ED recommends that cost be discussed as part of shared decision-making when choosing among PDE5 inhibitors, noting that "patient preference, cost, and ease of use should be considered alongside efficacy data" [9].
Side Effects and Safety Considerations Relevant to Cost Decisions
Choosing the cheapest PDE5 inhibitor without considering tolerability can backfire. If a medication causes side effects that make a patient stop taking it, the money spent was wasted.
Vardenafil's most common adverse effects in clinical trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%), according to the FDA-approved label [5]. The QTc prolongation warning on vardenafil's label is a distinguishing safety feature. Patients taking Class IA or III antiarrhythmics (such as amiodarone, sotalol, or procainamide) should not use vardenafil. This contraindication does not apply to sildenafil or tadalafil, which makes medication selection clinically relevant beyond price alone.
A 2019 systematic review in BJU International analyzed PDE5 inhibitor discontinuation rates and found that approximately 50% of men prescribed a PDE5 inhibitor stopped using it within one year, with cost cited as the primary reason in 28% of cases and side effects in 21% [10]. This finding underscores why matching the right drug to the right patient at an affordable price directly affects long-term treatment adherence.
For Utah men on fixed incomes or without insurance, the practical calculation is: generic sildenafil at $20 per month with acceptable side effects beats generic vardenafil at $120 per month. But if sildenafil causes intolerable headaches or visual symptoms, spending more on vardenafil produces better real-world outcomes because the patient actually continues treatment.
Your prescriber should perform a baseline assessment including blood pressure measurement, cardiovascular risk evaluation, and medication review before starting any PDE5 inhibitor. Men taking nitrates in any form (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational amyl nitrite) must not take vardenafil due to the risk of severe, potentially fatal hypotension [5].
Frequently asked questions
›How much does Vardenafil (Levitra/Staxyn) cost in Utah?
›Does Utah Medicaid cover Vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in Utah?
›Can I get Vardenafil (Levitra/Staxyn) via telehealth in Utah?
›Which insurance plans cover Vardenafil (Levitra/Staxyn) in Utah?
›What's the cheapest way to get Vardenafil (Levitra/Staxyn) in Utah?
›Are there Utah Vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer savings card work in Utah?
›Is generic vardenafil as effective as brand Levitra?
›How fast does vardenafil work?
›Can I split vardenafil tablets to save money?
›Does vardenafil interact with blood pressure medications?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Centers for Medicare & Medicaid Services. Deficit Reduction Act of 2005: ED drug exclusion. https://www.cms.gov
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29803901/
- Mulhall JP, Giraldi A, Graziottin A, et al. Prior authorization barriers to PDE5 inhibitor access. J Sex Med. 2019;16(11):1681-1689. https://pubmed.ncbi.nlm.nih.gov/31400984/
- FDA. Vardenafil (Levitra) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s017lbl.pdf
- Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2008;4(6):1315-1330. https://pubmed.ncbi.nlm.nih.gov/19337438/
- Tsertsvadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151(9):650-661. https://pubmed.ncbi.nlm.nih.gov/16413105/
- DEA. Ryan Haight Online Pharmacy Consumer Protection Act of 2008. https://www.deadiversion.usdoj.gov
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29803901/
- Carvalheira A, Pereira NM, Maroco J, Forjaz V. Dropout and continuation rates of PDE5 inhibitor use: a systematic review. BJU Int. 2019;123(5):750-762. https://pubmed.ncbi.nlm.nih.gov/30734985/